TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 70 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,004,000 | -54.9% | 13,338 | -83.9% | 0.01% | -68.4% |
| Q1 2022 | $2,225,000 | +116.9% | 82,853 | +285.2% | 0.02% | +90.0% |
| Q4 2021 | $1,026,000 | -21.4% | 21,508 | +9.5% | 0.01% | -37.5% |
| Q3 2021 | $1,305,000 | -31.4% | 19,650 | -19.4% | 0.02% | -23.8% |
| Q2 2021 | $1,902,000 | -45.8% | 24,377 | -34.3% | 0.02% | -53.3% |
| Q1 2021 | $3,511,000 | +52.3% | 37,117 | +96.2% | 0.04% | +40.6% |
| Q4 2020 | $2,305,000 | +78.0% | 18,917 | +27.6% | 0.03% | +68.4% |
| Q3 2020 | $1,295,000 | +340.5% | 14,825 | +125.4% | 0.02% | +137.5% |
| Q1 2020 | $294,000 | -79.2% | 6,578 | -71.0% | 0.01% | -69.2% |
| Q4 2019 | $1,413,000 | +1470.0% | 22,688 | +924.3% | 0.03% | +1200.0% |
| Q2 2019 | $90,000 | – | 2,215 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 308,686 | $13,786,000 | 8.42% |
| Cormorant Asset Management, LP | 3,056,797 | $136,517,000 | 6.34% |
| venBio Partners LLC | 160,333 | $7,160,000 | 6.10% |
| Burrage Capital Management LLC | 77,172 | $3,250,000 | 3.20% |
| Orbimed Advisors | 2,745,327 | $122,606,000 | 2.06% |
| Parkman Healthcare Partners LLC | 80,318 | $3,587,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 117,800 | $5,261,000 | 1.01% |
| DAFNA Capital Management LLC | 46,908 | $2,095,000 | 0.87% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $1,542,000 | 0.70% |
| Nicholas Investment Partners, LP | 75,487 | $3,371,000 | 0.66% |